Related Experiment Videos
Prophylaxis of stress ulcer bleeding. A meta-analysis
1Department of Anesthesiology, University of Bochum, Bergmannsheil, Federal Republic of Germany.
Journal of Clinical Gastroenterology
|January 1, 1991
Summary
For critically ill patients, sucralfate is more effective than antacids or H2-antagonists in preventing gastrointestinal bleeding and reducing pneumonia and mortality risks.
Area of Science:
- Critical Care Medicine
- Gastroenterology
- Pharmacology
Background:
- Stress-induced upper gastrointestinal bleeding affects 5-25% of intensive care unit (ICU) patients.
- Current prophylaxis with antacids and H2-antagonists shows limited efficacy and potential risks.
Purpose of the Study:
- To evaluate the efficacy of antacids, H2-antagonists, pirenzepine, and sucralfate in preventing stress bleeding.
- To assess the impact of these agents on pulmonary infections and mortality in ICU patients.
Main Methods:
- A meta-analysis of prospective studies on stress bleeding prevention was conducted.
- Studies included macroscopically visible bleeds and evaluated newer agents like pirenzepine and sucralfate.
- The analysis extended to include pulmonary infections and mortality data.
Main Results:
- Antacids and H2-antagonists were superior to no treatment, with a trend favoring antacids.
- Pirenzepine and sucralfate demonstrated superiority over H2-antagonists.
- Sucralfate was as effective as antacids; however, antacids and H2-antagonists increased pneumonia risk and mortality, especially in ventilated patients.
Conclusions:
- Sucralfate offers a superior safety and efficacy profile for stress bleeding prophylaxis in ICU patients compared to antacids and H2-antagonists.
- The findings suggest a re-evaluation of standard prophylaxis regimens in favor of agents with less impact on gastric pH.